Participation Form

We will notify the Study Coordinator for "Testing a disease specific treatment with ixazomib, lenalidomide, dexamethasone, and zoledronic acid versus zoledronic acid after radiation therapy in people with a plasma cell disorder known as solitary plasmacytoma of bone.," on your behalf, that you would like to participate in this study.

Please fill out the form below and click "Submit" to send a notification request.

or Cancel

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.